Adoptive tumor therapy with T lymphocytes enriched through an IFN-γ capture assay

Nature Medicine

Volumn 7, Issue 10, 2001, Pages 1159-1162

  Becker, Christian ^a   Pohla, Heike ^b   Frankenberger, Bernhard ^c   Schüler, Thomas ^a   Assenmacher, Mario ^d   Schendel, Dolores J ^c   Blankenstein, Thomas ^a,e  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d MILTENYI BIOTEC GMBH   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; ASSAY; CANCER IMMUNOTHERAPY; CELL ISOLATION; CELL SURFACE; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNIZATION; KIDNEY CARCINOMA; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR REJECTION;

ANIMALS; CARCINOMA, RENAL CELL; COLONIC NEOPLASMS; FEMALE; FIBROSARCOMA; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON TYPE II; KIDNEY NEOPLASMS; MICE; MICE, INBRED BALB C; NEOPLASMS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0034781060     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1001-1159     Document Type: Article

References (20)

1. Principles for adoptive T-cell therapy of human viral diseases
2. Prospects for adoptive T-cell therapy
3. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European group for blood and marrow transplantation working party chronic leukemia
4. Phenotypic analysis of antigen-specific T lymphocytes
5. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes
6. + T-cell responses in antitumor immunity
7. + tumor-infiltrating lymphocytes
8. + T cell-mediated tumor rejection involves inhibition of angiogenesis which is dependent on IFN-γ receptor expression by non-hematopoietic cells
9. + T cells based on cytokine secretion
10. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells
11. The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogeneous retroviral gene product
12. + T cells
13. Dendritic cells infiltrating tumors cotransduced with GM-CSF and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response
14. Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: Problems and perspectives for immunotherapy
15. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autotogous and allogeneic tumor lines
16. Human renal cell carcinoma antigen-specific CTLs: Antigen-driven selection and long-term persistence in vivo
17. Allogeneic vaccination for renal cell carcinoma: Development and monitoring
18. Expression of B7.1 (CD80) in a renal cell carcinoma line allows expansion of tumor-associated cytotoxic T lymphocytes in the presence of an alloresponse
19. Cellular immune response to human renal-cell carcinomas: Definition of a common antigen recognized by HLA-A2 restricted cytotoxic T-lymphocyte (CTL) clones
20. Adoptive cellular therapy